Altered expression of miRNAs was observed in both T1DM[28] and T2DM[29] including miR-185, which was shown to influence β-cell activity by targeting the mRNA of suppressor of cytokine signaling 3 (SOCS3)[30]. The gene discussed is SOCS3; the disease is type 1 diabetes mellitus.